Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer
- 1 August 1992
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 340 (8815) , 329-333
- https://doi.org/10.1016/0140-6736(92)91404-v
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- Controlling emesis related to cancer therapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Carboplatin Substitution for Cisplatin in the Treatment of Ovarian Carcinoma-- A Word of CautionJNCI Journal of the National Cancer Institute, 1989
- A Randomized Study of High-Dose versus Low-Dose cis-Platinum Combined with Cyclophosphamide in the Treatment of Advanced Ovarian CancerChemotherapy, 1989
- Stopping rules and estimation problems in clinical trialsStatistics in Medicine, 1988
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- High dose cisplatin compared with high dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group.BMJ, 1985
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958